FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer

[1]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[2]  Gary D Bader,et al.  Comprehensive identification of mutational cancer driver genes across 12 tumor types , 2013, Scientific Reports.

[3]  Gabor T. Marth,et al.  Integrative Annotation of Variants from 1092 Humans: Application to Cancer Genomics , 2013, Science.

[4]  David Tamborero,et al.  OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes , 2013, Bioinform..

[5]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[6]  Miguel Melo,et al.  Frequency of TERT promoter mutations in human cancers , 2013, Nature Communications.

[7]  T. Mikkelsen,et al.  Systematic dissection of regulatory motifs in 2000 predicted human enhancers using a massively parallel reporter assay. , 2013, Genome research.

[8]  Aaron R. Quinlan,et al.  GEMINI: Integrative Exploration of Genetic Variation and Genome Annotations , 2013, PLoS Comput. Biol..

[9]  A. Sivachenko,et al.  Punctuated Evolution of Prostate Cancer Genomes , 2013, Cell.

[10]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[11]  Gary L. Gallia,et al.  TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal , 2013, Proceedings of the National Academy of Sciences.

[12]  D. Schadendorf,et al.  TERT Promoter Mutations in Familial and Sporadic Melanoma , 2013, Science.

[13]  Eric S. Lander,et al.  Identifying Recent Adaptations in Large-Scale Genomic Data , 2013, Cell.

[14]  Peter Donnelly,et al.  Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer , 2012, Nature.

[15]  Gary D Bader,et al.  Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers , 2013 .

[16]  Manolis Kellis,et al.  Interpreting non-coding variation in complex disease genetics , 2012, Nature Biotechnology.

[17]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[18]  Shane J. Neph,et al.  Systematic Localization of Common Disease-Associated Variation in Regulatory DNA , 2012, Science.

[19]  Data production leads,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[20]  David Z. Chen,et al.  Architecture of the human regulatory network derived from ENCODE data , 2012, Nature.

[21]  Eurie L. Hong,et al.  Annotation of functional variation in personal genomes using RegulomeDB , 2012, Genome research.

[22]  Mark Gerstein,et al.  VAT: a computational framework to functionally annotate variants in personal genomes within a cloud-computing environment , 2012, Bioinform..

[23]  Bronwen L. Aken,et al.  GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.

[24]  D. Haussler,et al.  29 Mammalian Genomes Reveal Novel Exaptations of Mobile Elements for Likely Regulatory Functions in the Human Genome , 2012, PloS one.

[25]  Matthew B. Callaway,et al.  MuSiC: Identifying mutational significance in cancer genomes , 2012, Genome research.

[26]  ENCODEConsortium,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[27]  Benjamin P. Berman,et al.  FunciSNP: an R/bioconductor tool integrating functional non-coding data sets with genetic association studies to identify candidate regulatory SNPs , 2012, Nucleic acids research.

[28]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[29]  Manolis Kellis,et al.  HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..

[30]  S. Batzoglou,et al.  Linking disease associations with regulatory information in the human genome , 2012, Genome research.

[31]  Nikhil Wagle,et al.  High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. , 2012, Cancer discovery.

[32]  Kevin Y. Yip,et al.  Classification of human genomic regions based on experimentally determined binding sites of more than 100 transcription-related factors , 2012, Genome Biology.

[33]  Haiyuan Yu,et al.  HINT: High-quality protein interactomes and their applications in understanding human disease , 2012, BMC Systems Biology.

[34]  Noboru Jo Sakabe,et al.  Transcriptional enhancers in development and disease , 2012, Genome Biology.

[35]  A. Conesa,et al.  Differential expression in RNA-seq: a matter of depth. , 2011, Genome research.

[36]  Zhi John Lu,et al.  Analysis of genomic variation in non-coding elements using population-scale sequencing data from the 1000 Genomes Project , 2011, Nucleic acids research.

[37]  Eric S. Lander,et al.  The genomic complexity of primary human prostate cancer , 2010, Nature.

[38]  Mingming Jia,et al.  COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..

[39]  T. Mikkelsen,et al.  The NIH Roadmap Epigenomics Mapping Consortium , 2010, Nature Biotechnology.

[40]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[41]  Daniel Rios,et al.  Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor , 2022 .

[42]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[43]  J. Qian,et al.  Understanding protein phosphorylation on a systems level. , 2010, Briefings in functional genomics.

[44]  Nathaniel D. Heintzman,et al.  Histone modifications at human enhancers reflect global cell-type-specific gene expression , 2009, Nature.

[45]  Jean-Stéphane Varré,et al.  Efficient and accurate P-value computation for Position Weight Matrices , 2007, Algorithms for Molecular Biology.

[46]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[47]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[48]  Pall I. Olason,et al.  A human phenome-interactome network of protein complexes implicated in genetic disorders , 2007, Nature Biotechnology.

[49]  S. Batzoglou,et al.  Distribution and intensity of constraint in mammalian genomic sequence. , 2005, Genome research.

[50]  D. Haussler,et al.  Ultraconserved Elements in the Human Genome , 2004, Science.

[51]  T. Hubbard,et al.  A census of human cancer genes , 2004, Nature Reviews Cancer.

[52]  P. Stenson,et al.  Human Gene Mutation Database (HGMD®): 2003 update , 2003, Human mutation.

[53]  Anton Nekrutenko,et al.  Evolutionary dynamics of oncogenes and tumor suppressor genes: higher intensities of purifying selection than other genes. , 2003, Molecular biology and evolution.

[54]  Philip H. Ramsey.  Nonparametric Statistical Methods , 1974, Technometrics.

[55]  M. DePamphilis,et al.  HUMAN DISEASE , 1957, The Ulster Medical Journal.

[56]  D. Schadendorf,et al.  Highly Recurrent TERT Promoter Mutations in Human Melanoma , 2022 .